BRIEF published on 06/26/2026 at 13:35, 2 hours 33 minutes ago AlphaESS Expands Energy Storage Ecosystem in Europe at Intersolar 2026 Utility-scale Projects Energy Storage Software Integration AlphaESS Europe Market Connectivity
BRIEF published on 06/26/2026 at 13:35, 2 hours 33 minutes ago AlphaESS étend son écosystème de stockage d'énergie en Europe à Intersolar 2026 Stockage D'Énergie Intégration Logicielle Projets À Grande Échelle AlphaESS Europe Connectivité Au Marché
PRESS RELEASE published on 06/26/2026 at 13:30, 2 hours 38 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026 AlphaESS unveiled an expanded energy storage ecosystem for Europe at Intersolar 2026, showcasing their latest products and software solutions Europe Energy Storage Ecosystem Intersolar 2026 AlphaESS
Published on 06/26/2026 at 14:05, 2 hours 3 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 2 hours 8 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 3 hours 8 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 3 hours 23 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:30, 38 minutes ago JMGO Extends Special Savings Beyond Prime Day with N3 Ultimate at Its Best Price Since Launch
Published on 06/26/2026 at 15:23, 45 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/26/2026 at 15:23, 45 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/26/2026 at 07:00, 9 hours 8 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 9 hours 8 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
